Committee hears mixed views on prior authorization changes, a $25,000 'high‑dollar' threshold and a 1332 reinsurance authorization
Get AI-powered insights, summaries, and transcripts
Subscribe
Summary
Witnesses and regulators debated changes to utilization management — including a $25,000 numeric definition for 'high‑dollar' claims and narrowing of primary‑care prior‑authorization exemptions — and authorized agencies to apply for a Section 1332 reinsurance waiver to potentially lower premiums with federal pass‑through funding.
Lawmakers considered several utilization‑management changes and a reinsurance authorization at Thursday’s hearing, with insurers, providers and state officials outlining tradeoffs between controlling costs, reducing administrative burdens and protecting insurers’ solvency.
On 'high‑dollar' claims, the bill replaces an undefined standard by allowing targeted prepayment coding validation edit review for claims exceeding $25,000 per episode of care. Jen Carvey explained the numeric threshold was chosen to provide transparency and a bright line; committee members asked about whether the fixed amount should be inflation‑adjusted. Carvey and DFR staff said the statutory number can be changed later if it proves too low or high.
The proposal would also narrow the prior‑authorization exemption originally adopted in Act 111 so that only primary care providers practicing in truly independent physician practices not owned or controlled by hospitals remain exempt from PA requirements. Sponsors said hospitals and hospital‑employed PCPs have more administrative capacity and may have incentives that make exemption less appropriate; opponents urged waiting for two years of implementation data and independent surveys before rolling back protections that reduced prior‑authorization burdens for many providers.
On reinsurance, the bill authorizes the Department of Vermont Health Access (DIVA/DVHA), in consultation with DFR, to submit a Section 1332 state innovation waiver to establish a reinsurance program that could attract federal pass‑through funding. DFR and DIVA staff said prior modeling (most recently in a state marketplace report) suggested a hypothetical 10% individual‑market premium reduction might require an initial state investment on the order of $10 million and could have yielded about $27 million in federal pass‑through funds in one illustrative estimate. Regulators emphasized uncertainty because federal premium tax credit rules and past enhanced credits have changed the size of possible pass‑through funding.
Stakeholders differed on next steps. Hospitals and some legislators called for more actuarial analysis and caution about timing; regulators recommended pursuing technical actuarial work now to assess whether applying for a waiver would be worthwhile, with any program design and state funding decisions brought back for legislative approval.
The committee asked insurers and regulators for more data on utilization effects and premium impacts and signaled it will request further technical briefings before taking legislative action.